The Sanjiv K study demonstrated that the MTH1 inhibitor TH1579 eliminated primary AML primitive cells (CD45 +) and leukemic stem cells (CD45 + Lin‐CD34 + CD38 −). Here, PTPRC is linked to acute myeloid leukemia.